These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3567260)

  • 1. Antipsychotic drugs and plasma vasopressin in normals and acute schizophrenic patients.
    Raskind MA; Courtney N; Murburg MM; Backus FI; Bokan JA; Ries RK; Dorsa DM; Weitzman RE
    Biol Psychiatry; 1987 Apr; 22(4):453-62. PubMed ID: 3567260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
    Tada M; Shirakawa K; Matsuoka N; Mutoh S
    Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haloperidol versus chlorpromazine for schizophrenia.
    Leucht C; Kitzmantel M; Chua L; Kane J; Leucht S
    Cochrane Database Syst Rev; 2008 Jan; (1):CD004278. PubMed ID: 18254045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia.
    Reschke RW
    Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of the cytochrome P450 2D6 genotype for the drug metabolic interaction between chlorpromazine and haloperidol.
    Suzuki Y; Someya T; Shimoda K; Hirokane G; Morita S; Yokono A; Inoue Y; Takahashi S
    Ther Drug Monit; 2001 Aug; 23(4):363-8. PubMed ID: 11477317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma norepinephrine and dopamine-beta-hydroxylase activity in schizophrenia.
    Castellani S; Ziegler MG; van Kammen DP; Alexander PE; Siris SG; Lake CR
    Arch Gen Psychiatry; 1982 Oct; 39(10):1145-9. PubMed ID: 7125844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombocytopenia associated with chlorpromazine, haloperidol and thiothixene: a case report.
    Balon R; Berchou R; Zethelius M
    Can J Psychiatry; 1987 Mar; 32(2):149-50. PubMed ID: 3567823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of drug responses in schizophrenia: a method using a test dose of chlorpromazine.
    Minami H; Nakahara T; Miyahara A; Nakane Y
    Psychiatry Clin Neurosci; 1997 Aug; 51(4):217-22. PubMed ID: 9316167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADH secretion in schizophrenic patients on antipsychotic drugs.
    Sarai M; Matsunaga H
    Biol Psychiatry; 1989 Oct; 26(6):576-80. PubMed ID: 2571364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia. Theoretical implications for potency differences among neuroleptics.
    Singh MM; Kay SR
    Psychopharmacologia; 1975 Aug; 43(2):103-13. PubMed ID: 1103205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of antipsychotic drugs on memory functions of schizophrenic patients.
    Eitan N; Levin Y; Ben-Artzi E; Levy A; Neumann M
    Acta Psychiatr Scand; 1992 Jan; 85(1):74-6. PubMed ID: 1347670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two cases of deep vein thrombosis associated with antipsychotic drug use.
    Matsumoto M; Konno T; Tamba K; Abe T; Kato S; Kajii E
    Psychiatry Clin Neurosci; 2004 Aug; 58(4):450-1. PubMed ID: 15298663
    [No Abstract]   [Full Text] [Related]  

  • 13. Effectiveness of clozapine, haloperidol and chlorpromazine in schizophrenia during a five-year period.
    Ravanic DB; Dejanovic SM; Janjic V; Jovic SD; Milovanovic DR; Jakovljevic V; Pantovic V; Ravanic B; Pantovic M; Pantovic MM
    Arq Neuropsiquiatr; 2009 Jun; 67(2A):195-202. PubMed ID: 19547808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum lipids and lipoproteins in schizophrenic patients receiving major tranquilizers.
    Shafique M; Khan IA; Akhtar MH; Hussain I
    J Pak Med Assoc; 1988 Oct; 38(10):259-61. PubMed ID: 3144603
    [No Abstract]   [Full Text] [Related]  

  • 15. In vivo differentiation of cardiac vagal blocking effects of chlorpromazine and haloperidol.
    Schreiber G; Belmaker RH
    Biol Psychiatry; 1987 Nov; 22(11):1417-21. PubMed ID: 3663793
    [No Abstract]   [Full Text] [Related]  

  • 16. [Translation and application of the Simpson and Angus Scale of Extrapyramidal Symptoms].
    Lejoyeux M; Gorwood P; Stalla-Bourdillon A; Adès J
    Encephale; 1993; 19(1):17-21. PubMed ID: 8275889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Cost-effectiveness Analysis of Antipsychotics for Treatment of Schizophrenia in Uganda.
    Lubinga SJ; Mutamba BB; Nganizi A; Babigumira JB
    Appl Health Econ Health Policy; 2015 Oct; 13(5):493-506. PubMed ID: 25958192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haloperidol, clopenthixol, and chlorpromazine in chronic schizophrenia. Chemically unrelated antipsychotics as therapeutic alternatives.
    Serafetinides EA; Collins S; Clark ML
    J Nerv Ment Dis; 1972 Jan; 154(1):31-42. PubMed ID: 4550211
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of injectable haloperidol and chlorpromazine.
    Ritter RM; Davidson DE; Robinson TA
    Am J Psychiatry; 1972 Jul; 129(1):78-81. PubMed ID: 4556089
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuroleptic effects on platelet aggregation: a study in normal volunteers and schizophrenics.
    Dinan TG
    Psychol Med; 1987 Nov; 17(4):875-81. PubMed ID: 2893407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.